In some cancers, such as non-small cell lung cancer 27, pancreatic cancer 28, renal cell carcinoma 29, and T cell lymphoma 30, CEP55 is often highly expressed and promotes tumor development, thereby becoming an effective diagnostic marker. This evidence concerns the gene CEP55 and renal cell carcinoma.